Adverum Biotechnologies
Biotechnology-Research
Website
Company Tagline
We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss.
Industry Category
Business Keywords
Company Description
Adverum Biotechnologies is a leading clinical-stage biotechnology company dedicated to establishing gene therapy as a transformative standard of care for prevalent ocular diseases. With a strong commitment to developing functional cures, Adverum Biotechnologies aims to restore vision and prevent blindness, making a profound societal impact worldwide.
Located at 100 Cardinal Way, Redwood City, California 94063, US, Adverum Biotechnologies leverages its proprietary intravitreal (IVT) platform to develop durable, single-administration therapies. These innovative treatments are designed for convenient delivery in physicians' offices, eliminating the need for frequent ocular injections. Adverum Biotechnologies is currently evaluating ixoberogene soroparvovec (Ixo-vec), a novel gene therapy candidate, as a one-time IVT injection for patients with neovascular or wet age-related macular degeneration.
Adverum Biotechnologies is committed to overcoming the challenges associated with current treatment paradigms, striving to transform the standard of care and preserve vision for patients globally. We invite the management team at Adverum Biotechnologies to create a customized and exclusive company showcase and product listing on our platform to further enhance its commercial development.
Adverum Biotechnologies est une entreprise de biotechnologie de pointe au stade clinique, dédiée à l'établissement de la thérapie génique comme norme de soins transformatrice pour les maladies oculaires prévalentes. Avec un fort engagement envers le développement de traitements fonctionnels, Adverum Biotechnologies vise à restaurer la vision et à prévenir la cécité, ayant ainsi un impact sociétal profond dans le monde entier.
Située au 100 Cardinal Way, Redwood City, Californie 94063, États-Unis, Adverum Biotechnologies exploite sa plateforme intravitréenne (IVT) exclusive pour développer des thérapies durables à administration unique. Ces traitements innovants sont conçus pour une administration pratique dans les cabinets médicaux, éliminant ainsi le besoin d'injections oculaires fréquentes. Adverum Biotechnologies évalue actuellement l'ixoberogene soroparvovec (Ixo-vec), un nouveau candidat de thérapie génique, comme injection IVT unique pour les patients atteints de dégénérescence maculaire néovasculaire ou humide liée à l'âge.
Adverum Biotechnologies s'engage à surmonter les défis associés aux paradigmes de traitement actuels, en s'efforçant de transformer la norme de soins et de préserver la vision des patients du monde entier. Nous invitons l'équipe de direction d'Adverum Biotechnologies à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de renforcer davantage son développement commercial.
Key Personnel / Employees
Compare Companies Side by Side
Compare Adverum Biotechnologies with 3 companies in Biotechnology-Research
| Comparison Field |
Adverum BiotechnologiesMain Company |
MONA HealthView Profile |
4D Molecular Therape...View Profile |
Morgan Prestwich - L...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2020 | 2013 | 2010 |
|
Company Size
|
— | 2-10 | 51-200 | 11-50 |
|
City
|
Redwood City, California | Bertem, Flemish Region | Emeryville, California | Reigate, Surrey |
|
Country
|
United States | United States | United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
9 Total Skills
Gene Therapy
Biotechnology
Ophthalmology
Retinal Diseases
Drug Development
Clinical Research
Biopharmaceuticals
Rare Diseases
Retina
|
4 Total
4 Unique
Unique Skills:
Artificial Intelligence
Diabetic Retinopathy
Glaucoma
Individualised medecine
|
5 Total
5 Unique
Unique Skills:
Adeno-Associated Virus
Clinical
Clinical Trials
Lab
Science
|
53 Total
53 Unique
Unique Skills:
Biotech
Biotech Recruitment
Biotechnology Recruitment
Boards
Business Development
Cell Therapy
+47
|
4
Total Companies2010
Oldest Founded2
Countries70
Unique SkillsSimilar Companies
Other organizations in the same industry
Filamon Limited
Biotechnology-ResearchA drug discoverer and drug developer for major pharma
Turing Biosystems
Biotechnology-ResearchHarnessing the power of computation to deliver the right drugs, for the right people, at the right t...
KlyneAI
Biotechnology-ResearchTransforming drug discovery with accessible software-based biotech solutions 🌟 Contact: Klyne@klyne...
Alternative Company Names
This company is also known as